Last10K.com

Bungeltd (BG) SEC Filing 10-Q Quarterly report for the period ending Wednesday, September 30, 2020

SEC Filings

Bunge Ltd

CIK: 1144519 Ticker: BG

 

Bunge Reports Third Quarter 2020 Results

St. Louis, MO - October 28, 2020 - Bunge Limited (NYSE:BG) today reported third quarter 2020 results.

Q3 GAAP EPS of $1.84 vs. $(10.57) in the prior year; $2.47 vs. $1.28 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences
Strong results driven by outstanding execution across Bunge’s global platform
Exceptional Agribusiness performance driven by oilseed processing, which benefited from higher margins and volumes
Edible Oils results better than expected; year to date results higher than prior year despite COVID-19 impacts
Increasing full-year adjusted EPS outlook to between $6.25 and $6.75 based on strong Q3 results and improving market trends

 

Ø Overview

 

Greg Heckman, Bunge’s Chief Executive Officer, commented, “Our team delivered a strong third quarter with outstanding execution across our global platform, leveraging improving market trends. We achieved record crush utilization and captured exceptionally strong margins while supporting our customers and maintaining measures to protect the health of our employees. These results, and our performance over the past few quarters, reflect the meaningful changes we’ve made to our operating model, portfolio and financial approach.

 

“Looking into next year, we expect many of the favorable trends to continue with demand for our products remaining strong. We also expect additional global demand for vegetable oil from the growth of biofuels. With our strength in oilseed processing, in addition to our global origination and distribution capabilities, we believe we are well positioned to meet market demands and capitalize on this growth.”

 

 

 

 

 

 

 

 

  1 

 

Ø  Financial Highlights

 

  Quarter Ended
September 30,
   Nine Months Ended
September 30,
US$ in millions, except per share data 2020 2019   2020 2019
Net income attributable to Bunge $ 262    $ (1,488)     $ 594    $ (1,229)  
           
Net income per common share-diluted $ 1.84    $ (10.57)     $ 3.98    $ (8.87)  
           
Mark-to-market timing difference (a) $ 0.85    $ (0.13)     $ 0.97    $ (0.25)  
Certain (gains) and charges (b) $ (0.14)   $ 11.30      $ 0.32    $ 11.50   
Dilutive share basis difference - GAAP vs Adjusted (c) $ —    $ 0.68      $ —    $ 0.69   
Adjustment of redeemable noncontrolling interest (d) $ (0.08)   $ —      $ (0.01)   $ —   
Adjusted Net income per common share-diluted (e) $ 2.47    $ 1.28      $ 5.26    $ 3.07   
           
Core Segment EBIT (e) (f) $ 420    $ 202      $ 1,305    $ 709   
Mark-to-market timing difference (a) 161    (25)     186    (47)  
Certain (gains) & charges (b) —    110      —    123   
Adjusted Core Segment EBIT (e) $ 581    $ 287      $ 1,491    $ 785   
           
Corporate and Other EBIT (e) $ (92)   $ (99)     $ (274)   $ (77)  
Certain (gains) & charges (b) —    30      71    45   
Adjusted Corporate and Other EBIT (e) $ (92)   $ (69)     $ (203)   $ (32)  
           
Non-core Segment EBIT (e) (g) $ 23    $ (1,543)     $ (112)   $ (1,567)  
Certain (gains) & charges (b) —    1,604      —    1,607   
Adjusted Non-core Segment EBIT (e) $ 23    $ 61      $ (112)   $ 40   
           
Total Segment EBIT (e) $ 351    $ (1,440)     $ 919    $ (935)  
Mark-to-market timing difference (a) 161    $ (25)     $ 186    $ (47)  
Total Certain (gains) & charges (b) —    $ 1,744      $ 71    $ 1,775   
Adjusted Total Segment EBIT (e) $ 512    $ 279      $ 1,176    $ 793   
           
(a)Mark-to-market timing impact of certain commodity and freight contracts, readily marketable inventories, and related hedges associated with committed future operating capacity. See note 3 in the Additional Financial information section of this release for details.
(b)Certain (gains) & charges included in Total Segment EBIT. See Additional Financial Information for details.
(c)Dilutive share basis difference - GAAP vs. Adjusted represents the impact of using different weighted-average common shares outstanding in the denominators of the respective GAAP and Adjusted EPS calculations. See note 4 in the Additional Financial information section of this release for for details.
(d)Retained earnings impact associated with an adjustment to the carrying amount of the redeemable noncontrolling interest recorded in respect of our 70% ownership interest in Loders. See note 5 in the Additional Financial information section of this release for for details.
(e)Core Segment EBIT, Adjusted Core Segment EBIT, Corporate and Other EBIT, Adjusted Corporate and Other EBIT, Non-core Segment EBIT, Adjusted Non-core Segment EBIT, Total Segment EBIT, Adjusted Total Segment EBIT, and Adjusted Net income per common share-diluted are non-GAAP financial measures. Reconciliations to the most directly comparable U.S. GAAP measures are included in the tables attached to this press release and the accompanying slide presentation posted on Bunge’s website.
(f)Core Segment earnings before interest and tax (“Core Segment EBIT”) comprises the aggregate earnings before interest and tax (“EBIT”) of Bunge’s Agribusiness, Edible Oils Products, Milling Products and Fertilizer reportable segments, and excludes Bunge’s Sugar & Bioenergy reportable segment and Corporate and Other activities.
(g)Non-core Segment EBIT comprises Bunge’s Sugar & Bioenergy reportable segment EBIT, which reflects Bunge’s share of the results of its 50/50 joint venture with BP p.l.c.

 

  2 

 

Ø Third Quarter Results

Core Segments

Agribusiness

  Quarter Ended   Nine Months Ended
US$ in millions, except per share data Sep 30, 2020 Sep 30, 2019    Sep 30, 2020 Sep 30, 2019
Volumes (in thousand metric tons) 35,887    36,554      107,222    104,992   
           
Net Sales $ 7,108    $ 7,008      $ 20,247    $ 20,995   
           
Gross Profit $ 355    $ 249      $ 1,229    $ 791   
           
Selling, general and administrative expense $ (147)   $ (113)     $ (367)   $ (351)  
           
Foreign exchange gains (losses) $ 59    $ (57)     $ 76    $ (76)  
           
Income (loss) from affiliates $ 18    $ 10      $ 43    $ 24   
           
Segment EBIT $ 299    $ 107      $ 1,015    $ 457   
Mark-to-market timing difference 168    (25)     175    (47)  
Certain (gains) & charges —    92      —    102   
Adjusted Segment EBIT $ 467    $ 174      $ 1,190    $ 512   
           
Certain (gains) & charges, Net Income (Loss) Attributable to Bunge $ —    $ 85      $ —    $ 95   
Certain (gains) & charges, Earnings Per Share $ —    $ 0.56      $ —    $ 0.63   

 

Oilseeds (2)

  Quarter Ended   Nine Months Ended
US$ in millions, except per share data Sep 30, 2020 Sep 30, 2019    Sep 30, 2020 Sep 30, 2019
Oilseeds EBIT $ 230    $ 69      $ 622    $ 349   
Mark-to-market timing difference 162    (25)     154    (47)  
Certain (gains) & charges —    68      —    77   
Adjusted Oilseed EBIT $ 392    $ 112      $ 776    $ 379   

In Oilseeds, soy processing results were higher in South America, Europe and Asia, where margins increased from strong meal and vegetable oil demand, partially offset by slightly lower results in the U.S. Softseed processing results increased in all regions. Lower variable per unit costs also contributed to improved performance. Higher results in trading and distribution operations were due to increased margins and favorable positioning.

 

  3 

 

Grains (2)

  Quarter Ended    Nine Months Ended
US$ in millions, except per share data Sep 30, 2020   Sep 30, 2019     Sep 30, 2020   Sep 30, 2019  
Grains EBIT $ 69    $ 38      $ 393    $ 108   
Mark-to-market timing difference   —      21    —   
Certain (gains) & charges —    24      —    25   
Adjusted Grains EBIT $ 75    $ 62      $ 414    $ 133   

In Grains, higher results were primarily driven by origination in South America, which benefited from strong execution and farmer selling as crop prices in local currency increased during the quarter.

 

 

Edible Oil Products

  Quarter Ended   Nine Months Ended
US$ in millions, except per share data Sep 30, 2020   Sep 30, 2019      Sep 30, 2020   Sep 30, 2019 
Volumes (in thousand metric tons) 2,473    2,462      7,101    7,099   
           
Net Sales $ 2,434    $ 2,319      $ 6,886    $ 6,764   
           
Gross Profit $ 177    $ 160      $ 451    $ 450   
           
Selling, general and administrative expense $ (96)   $ (86)     $ (278)   $ (262)  
           
Foreign exchange gains (losses) $ (3)   $     $ —    $  
           
Income (loss) from affiliates $ —    $ —      $ —    $ —   
           
Segment EBIT $ 76    $ 59      $ 173    $ 161   
Mark-to-market timing difference (9)   —        —   
Certain (gains) & charges —    13      —    14   
Adjusted Segment EBIT $ 67    $ 72      $ 181    $ 175   
           
Certain (gains) & charges, Net Income (Loss) Attributable to Bunge $ —    $ 13      $ —    $ 14   
Certain (gains) & charges, Earnings Per Share $ —    $ 0.08      $ —    $ 0.09   
           

Edible Oil Products Summary

 

Results improved significantly from the second quarter, but were down from a strong prior year. Higher earnings in Brazil and Asia from improved demand in food processor and consumer retail channels were more than offset by lower earnings in North America and Europe.

 

  4 

 

Milling Products

  Quarter Ended    Nine Months Ended
US$ in millions, except per share data Sep 30, 2020  Sep 30, 2019    Sep 30, 2020  Sep 30, 2019 
Volumes (in thousand metric tons) 1,180    1,131      3,455    3,349   
           
Net Sales $ 416    $ 437      $ 1,213    $ 1,293   
           
Gross Profit $ 38    $ 41      $ 135    $ 130   
           
Selling, general and administrative expense $ (22)   $ (24)     $ (70)   $ (75)  
           
Foreign exchange gains (losses) $   $ —      $   $  
           
Income (loss) from affiliates $ (1)   $ —      $ (1)   $ —   
           
Segment EBIT $ 16    $ 14      $ 64    $ 61   
Mark-to-market timing difference   —        —   
Certain (gains) & charges —        —     
Adjusted Segment EBIT $ 18    $ 19      $ 67    $ 68   
           
Certain (gains) & charges, Net Income (Loss) Attributable to Bunge $ —    $     $ —    $  
Certain (gains) & charges, Earnings Per Share $ —    $ 0.03      $ —    $ 0.04   

 

Milling Products Summary

 

Higher results in Brazil, which were primarily driven by increased volumes, were slightly offset by lower margins in Mexico. Results in the U.S. were comparable to last year.

 

 

 

  5 

 

Fertilizer

  Quarter Ended   Nine Months Ended
US$ in millions, except per share data Sep 30, 2020  Sep 30, 2019     Sep 30, 2020  Sep 30, 2019 
Volumes (in thousand metric tons) 485    512      1,036    1,013   
           
Net Sales $ 153    $ 178      $ 324    $ 355   
           
Gross Profit $ 30    $ 28      $ 61    $ 44   
           
Selling, general and administrative expense $ —    $ (5)     $ (7)   $ (12)  
           
Foreign exchange gains (losses) $   $ —      $   $ —   
           
Income (loss) from affiliates $ —    $ —      $ —    $ —   
           
Segment EBIT $ 29    $ 22      $ 53    $ 30   
Certain (gains) & charges —    $ —      $ —    $ —   
Adjusted Segment EBIT $ 29    $ 22      $ 53    $ 30   
           
Certain (gains) & charges, Net Income (Loss) Attributable to Bunge $ —    $ —      $ —    $ —   
Certain (gains) & charges, Earnings Per Share $ —    $ —      $ —    $ —   

 

Fertilizer Summary

 

Higher segment results reflected improved performance in our Argentine operation driven by higher margins, partially offset by lower volumes.

 

 

Corporate and Other

 

  Quarter Ended    Nine Months Ended
US$ in millions, except per share data Sep 30, 2020  Sep 30, 2019    Sep 30, 2020  Sep 30, 2019 
Gross Profit $ (3)   $ (1)     $ (2)   $ 10   
           
Selling, general and administrative expense $ (87)   $ (91)     $ (270)   $ (239)  
           
Foreign exchange gains (losses) $ (4)   $     $ (3)   $  
           
Other income (expense) - net $   $ (8)     $   $ 150   
           
Segment EBIT (a) $ (92)   $ (99)     $ (274)   $ (77)  
Certain (gains) & charges —    30      71    45   
Adjusted Segment EBIT $ (92)   $ (69)     $ (203)   $ (32)  
           
Certain (gains) & charges, Net Income (Loss) Attributable to Bunge $ (21)   $ (6)     $ 48    $  
Certain (gains) & charges, Earnings Per Share $ (0.14)   $ (0.04)     $ 0.32    $ 0.05   

 

  6 

 

Corporate

  Quarter Ended    Nine Months Ended
US$ in millions, except per share Sep 30, 2020 Sep 30, 2019   Sep 30, 2020 Sep 30, 2019
Corporate EBIT $ (94)   $ (95)     $ (220)   $ (235)  
Certain (gains) & charges —    30        45   
Adjusted Corporate EBIT $ (94)   $ (65)     $ (215)   $ (190)  

Other

  Quarter Ended    Nine Months Ended
US$ in millions, except per share Sep 30, 2020  Sep 30, 2019    Sep 30, 2020  Sep 30, 2019 
Other EBIT $   $ (4)     $ (54)   $ 158   
Certain (gains) & charges —    —      66    —   
Adjusted Other EBIT $   $ (4)     $ 12    $ 158   

 

Corporate and Other Summary

 

Corporate includes salaries and overhead for corporate functions, and Other comprises the results of Bunge Ventures and the Company’s securitization, captive insurance and other activities. Total adjusted segment EBIT for Corporate and Other was comprised of $(94) million from Corporate and $2 million from Other for the quarter ended September 30, 2020. This compares to $(65) million from Corporate and $(4) million from Other for the prior year period. The increase in Corporate expenses during the quarter primarily related to higher performance-based compensation driven by strong financial performance.

 

 

 

 

 

 

 

 

  7 

 

Non-core Segments

 

Sugar & Bioenergy

  Quarter Ended    Nine Months Ended
US$ in millions, except per share data Sep 30, 2020  Sep 30, 2019    Sep 30, 2020  Sep 30, 2019 
Volumes (in thousand metric tons) 96    1,083      244    2,727   
           
Net Sales $ 48    $ 381      $ 124    $ 950   
           
Gross Profit $   $ (1,455)     $   $ (1,454)  
           
Selling, general and administrative expense $ —    $ (10)     $ (1)   $ (30)  
           
Foreign exchange gains (losses) $ —    $ (78)     $ —    $ (80)  
           
Income (loss) from affiliates $ 18    $ (2)     $ (118)   $ (3)  
           
Segment EBIT $ 23    $ (1,543)     $ (112)   $ (1,567)  
Certain (gains) & charges —    1,604      —    1,607   
Adjusted Segment EBIT $ 23    $ 61      $ (112)   $ 40   
           
Certain (gains) & charges, Net Income (Loss) Attributable to Bunge $ —    $ 1,604      $ —    $ 1,607   
Certain (gains) & charges, Earnings Per Share $ —    $ 10.67      $ —    $ 10.69   

Sugar & Bioenergy Summary

 

Segment results for this quarter reflected our share of the results of the 50/50 joint venture with BP. By contrast, third quarter 2019 reflected our 100 percent ownership of the Brazilian sugar and bioenergy operations that we contributed to the joint venture in December 2019. Additionally, results of the joint venture are reported on a one-month lag.

 

Results in the quarter benefited from higher year-over-year average sugar and ethanol prices in local currency, as well as improved industrial efficiency and costs. Earnings in the third quarter of last year benefited from $32 million of lower depreciation due to our Brazilian sugar and bioenergy operations being classified as held for sale.

 

 

 

 

 

  8 

 

Cash Flow

  Nine Months Ended
  Sep 30, 2020 Sep 30, 2019
Cash used for operating activities $ (2,128)   $ (1,313)  
Proceeds from beneficial interest in securitized trade receivables 1,164    800   
Cash used for operating activities, adjusted $ (964)    $ (513)  

 

Cash used for operations in the nine months ended September 30, 2020 was $2,128 million compared to cash used of $1,313 million in the same period last year. Adjusting for the proceeds from beneficial interest in securitized trade receivables, cash used by operating activities was $964 million compared with cash used for operating activities of $513 million in the prior year. This increase in cash used for operations was primarily driven by higher working capital levels, reflecting higher commodity prices and increased purchases of readily marketable inventory.

 

Income Taxes

For the three and nine months ended September 30, 2020, income tax expense was $38 million and $151 million, respectively, compared to $(28) million and $70 million, respectively, for the three and nine months ended September 30, 2019. The increase in income tax expense during 2020 is primarily due to higher pre-tax income in 2020.

 

Ø COVID-19 Update

 

Bunge continues to take proactive steps to protect the health and safety of its employees, their families and the communities in which it operates. Through an internal task force, the Company closely monitors developments related to the pandemic and provides guidance to its facilities worldwide. Each of Bunge’s facilities around the globe is taking steps to respond to COVID-19 based on the nature of its operations and the actions being taken by local governments. The Company has continued to restrict travel, follow upgraded cleaning practices at its facilities and offices, require remote work arrangements for teammates wherever possible, reduce staffing in its production facilities and keep social distancing and other safety related measures in place.

 

Numerous countries around the globe, including places where Bunge operates production facilities or maintains offices, have continued to impose quarantines and significant restrictions, including shelter-in-place or stay-at-home orders. Additionally, the rise in the number of observed COVID-19 cases in many parts of the world may lead to governments re-imposing travel and work restrictions or imposing additional restrictions. In locations where such restrictions are in place, Bunge has been deemed an essential or life-sustaining operation. To date, the Company has not seen a significant disruption in its supply chain, has been able to mitigate logistics and distribution issues that have arisen, and substantially all of its facilities around the world have continued to operate at or near normal levels. Bunge continues to monitor local, regional and national governmental actions that could limit or restrict the movement of agricultural commodities or products or otherwise disrupt physical product flows or its ability to operate in the future.

 

 

 

  9 

 

Ø Outlook

 

Excluding notable items and mark-to-market timing differences, we now expect full-year adjusted earnings of between $6.25 and $6.75 per share.

 

In Agribusiness, our improved outlook reflects our third quarter year-to-date results, the current market environment and forward curves.

 

In Edible Oils, we now expect adjusted results to be up compared to last year due to the strong performance of our consumer businesses and growing biofuel demand. Expected full-year adjusted results in Milling continue to be in line with last year.

 

In Fertilizer, we now expect full-year adjusted results to be slightly higher than last year.

 

Corporate and Other is expected to be comparable to last year, excluding Bunge Ventures.

 

For 2020, the Company expects an adjusted annual effective tax rate in the range of 20% to 22%; net interest expense of approximately $230 million; capital expenditures in the range of $375 to $400 million; and depreciation and amortization of approximately $430 million.

 

Ø Conference Call and Webcast Details

Bunge Limited’s management will host a conference call at 8:00 a.m. Eastern (7:00 a.m. Central) on Wednesday, October 28, 2020 to discuss the company’s results.

Additionally, a slide presentation to accompany the discussion of results will be posted on www.bunge.com.

To listen to the call, please dial 1 (844) 735-3666. If you are located outside the United States or Canada, dial +1 (412) 317-5706. Please dial in five to 10 minutes before the scheduled start time. The call will also be webcast live at www.bunge.com.

To access the webcast, go to “Events and presentations” in the “Investors” section of the company’s website. Select “Q3 2020 Bunge Limited Conference Call” and follow the prompts. Please go to the website at least 15 minutes prior to the call to register and download any necessary audio software.

 

A replay of the call will be available later in the day on October 28, 2020, continuing through November 28, 2020. To listen to it, please dial 1 (877) 344-7529 in the United States, 1 (855) 669-9658 in Canada, or +1 (412) 317-0088 in other locations. When prompted, enter confirmation code 10148043. A replay will also be available in “Past events” at “Events and presentations” in the “Investors” section of the company’s website.

Ø About Bunge Limited

Bunge (www.bunge.com, NYSE: BG) is a world leader in sourcing, processing and supplying oilseed and grain products and ingredients. Founded in 1818, Bunge’s expansive network feeds and fuels a growing world, creating sustainable products and opportunities for more than 70,000 farmers and the consumers they serve across the globe. The company is headquartered in St. Louis, Missouri and has approximately 25,000 employees who stand behind more than 350 port terminals, oilseed processing plants, grain silos, and food and ingredient production and packaging facilities around the world.

 

  10 

 

Ø Website Information

We routinely post important information for investors on our website, www.bunge.com, in the “Investors” section. We may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investors section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  11 

 

Ø Cautionary Statement Concerning Forward-Looking Statements

This press release contains both historical and forward-looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). These forward looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward looking statements by using words including “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “plan,” “intend,” “estimate,” “continue” and similar expressions. These forward looking statements are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward looking statements. The following important factors, among others, could cause actual results to differ from these forward-looking statements: industry conditions, including fluctuations in supply, demand and prices for agricultural commodities and other raw materials and products used in our business, fluctuations in energy and freight costs; competitive developments in our industries; the effects of weather conditions and the outbreak of crop and animal disease on our business; global and regional economic, agricultural, financial and commodities market, political, social and health conditions; the impacts of pandemic outbreaks, including COVID-19; the outcome of pending regulatory and legal proceedings; our ability to complete, integrate and benefit from acquisitions, dispositions, joint ventures and strategic alliances; our ability to achieve the efficiencies, savings and other benefits anticipated from our cost reduction, margin improvement, operational excellence and other business optimization initiatives; changes in government policies, laws and regulations affecting our business, including agricultural and trade policies and environmental, tax and biofuels regulation; our capital allocation plans, funding needs and financing sources; changes in foreign exchange policy or rates; the outcome of our portfolio rationalization initiatives; the effectiveness of our risk management strategies; our ability to attract and retain executive management and key personnel; operational risks, including industrial accidents, natural disasters and cybersecurity incidents; and other factors affecting our business generally. The forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

 

 

Investor Contact:

Ruth Ann Wisener

Bunge Limited

636-292-3014

ruthann.wisener@bunge.com

Media Contact:

Bunge News Bureau

Bunge Limited

914-272-0297

news@bunge.com

 

 

 

 

 

 

 

  12 

 

Ø Additional Financial Information

Certain gains and (charges), quarter-to-date

The following tables provide a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on net income (loss) attributable to Bunge, earnings per share diluted and segment EBIT for the three month periods ended September 30, 2020 and 2019.

(US$ in millions, except per share data) Net Income (Loss)
Attributable to
Bunge
Earnings
Per Share
Diluted
Segment
EBIT
Quarter Ended September 30, 2020 2019 2020 2019 2020 2019
             
Core Segments: $ —    $ (102)    $ —    $ (0.67)    $ —    $ (110)  
Agribusiness $ —    $ (85)    $ —    $ (0.56)    $ —    $ (92)  
Severance, employee benefit, and other costs —    (2)   —    (0.01)   —    (2)  
Impairment charges —    (72)   —    (0.48)   —    (79)  
Expired indemnification asset —    (11)   —    (0.07)   —    (11)  
             
Edible Oil Products $ —    $ (13)    $ —    $ (0.08)    $ —    $ (13)  
Severance, employee benefit, and other costs —    (1)   —    —    —    (1)  
Impairment charges —    (12)   —    (0.08)   —    (12)  
             
Milling Products $ —    $ (4)    $ —    $ (0.03)    $ —    $ (5)  
Impairment charges —    (4)   —    (0.03)   —    (5)  
             
             
Fertilizer $ —    $ —     $ —    $ —     $ —    $ —   
             
             
Corporate and Other: $ 21    $    $ 0.14    $ 0.04     $ —    $ (30)  
Severance, employee benefit, and other costs —    (5)   —    (0.04)   —    (8)  
Income tax benefits 21    30    0.14    0.20    —    —   
Impairment charges —    (19)   —    (0.12)   —    (22)  
             
             
Non-core Segment: $ —    $ (1,604)    $ —    $ (10.67)    $ —    $ (1,604)  
Sugar & Bioenergy $ —    $ (1,604)    $ —    $ (10.67)    $ —    $ (1,604)  
Sugar restructuring charges —    (1)   —    (0.01)   —    (1)  
Charges related to assets classified as held for sale —    (1,603)   —    (10.66)   —    (1,603)  
             
Total $ 21    $ (1,700)    $ 0.14    $ (11.30)    $ —    $ (1,744)  
             

See Definition and Reconciliation of Non-GAAP Measures.

 

  13 

 

Core Segments

Agribusiness

EBIT for the quarter ended September 30, 2019 included $1 million of severance and other employee benefit costs related to the Company’s Global Competitiveness Plan (GCP), recorded in SG&A, a further $1 million of severance and other employee benefit costs related to other industrial initiatives, recorded in COGS, $79 million of PP&E impairment charges at certain facilities subject to the Company’s portfolio rationalization initiatives, recorded in COGS, and an $11 million charge related to the reversal of an expired indemnification asset in connection with an uncertain tax position, recorded in SG&A.

Edible Oil Products

EBIT for the quarter ended September 30, 2019 included $1 million of severance and other employee benefit costs related to the GCP, recorded in SG&A, and $12 million of PP&E impairment charges at certain facilities subject to the Company’s portfolio rationalization initiatives, recorded in COGS.

Milling Products

EBIT for the quarter ended September 30, 2019 included $5 million of PP&E impairment charges at certain facilities subject to the Company’s portfolio rationalization initiatives, recorded in COGS.

Corporate and Other

Net Income for the quarter ended September 30, 2020 included a $21 million benefit related to the reversal of a deferred tax asset valuation allowance in Europe.

EBIT for the quarter ended September 30, 2019 included $8 million of severance and other employee benefit costs related to the GCP, included in SG&A, and $22 million of impairment charges related to the relocation of the Company’s global headquarters, recorded in SG&A. Net Income also included income tax benefits of $30 million during the quarter ended September 30, 2019, of which $19 million related to the favorable resolution of uncertain tax positions in Asia, and $11 million related to the lapse of statutes of limitations on unrecognized tax benefits in Europe.

Non-core Segment

Sugar & Bioenergy

EBIT for the quarter ended September 30, 2019 included $1,524 million of impairment charges, recorded in COGS, and $79 million of foreign currency losses on intercompany loans no longer classified as permanently invested, recorded in Foreign exchange gains (losses). Both such items related to the classification of the Company’s Brazilian sugar and bioenergy operations as held for sale. EBIT for the quarter ended September 30, 2019 also included $1 million of restructuring charges, recorded in COGS.

 

 

  14 

 

Certain gains and (charges), year-to-date

 

The following tables provide a summary of certain gains and (charges) that may be of interest to investors, including a description of these items and their effect on net income (loss) attributable to Bunge, earnings per share diluted and total segment EBIT for the nine month periods ended September 30, 2020 and 2019.

(US$ in millions, except per share data) Net Income (Loss)
Attributable to
Bunge
Earnings
Per Share
Diluted
Segment
EBIT
Nine Months Ended September 30, 2020 2019 2020 2019 2020 2019
             
Core Segments: $ —    $ (114)    $ —    $ (0.76)    $ —    $ (123)  
Agribusiness $ —    $ (95)    $ —    $ (0.63)    $ —    $ (102)  
Severance, employee benefit, and other costs —    (6)   —    (0.04)   —    (6)  
Impairment charges —    (78)   —    (0.52)   —    (85)  
Expired indemnification asset —    (11)   —    (0.07)   —    (11)  
             
Edible Oil Products $ —    $ (14)    $ —    $ (0.09)    $ —    $ (14)  
Impairment charges —    (12)   —    (0.08)   —    (12)  
Acquisition and integration costs —    (1)   —    (0.01)   —    (1)  
Severance, employee benefit, and other costs —    (1)   —    —    —    (1)  
             
Milling Products $ —    $ (5)    $ —    $ (0.04)    $ —    $ (7)  
Impairment charges —    (12)   —    (0.09)   —    (16)  
Gain on arbitration settlement —      —    0.05    —     
             
Fertilizer $ —    $ —     $ —    $ —     $ —    $ —   
             
             
Corporate and Other: $ (48)   $ (6)    $ (0.32)   $ (0.05)    $ (71)   $ (45)  
Severance, employee benefit, and other costs (3)   (15)   (0.02)   (0.11)   (5)   (21)  
Acquisition and integration costs —    (2)   —    (0.01)   —    (2)  
Commercial claim provision (66)   —    (0.44)   —    (66)   —   
Income tax benefits 21    30    0.14    0.20    —    —   
Impairment charges —    (19)   —    (0.13)   —    (22)  
             
Non-core Segment: $ —    $ (1,607)    $ —    $ (10.69)    $ —    $ (1,607)  
Sugar & Bioenergy $ —    $ (1,607)   $ —    $ (10.69)    $ —    $ (1,607)  
Sugar restructuring charges —    (4)   —    (0.03)   —    (4)  
Charges related to assets classified as held for sale —    (1,603)   —    (10.66)   —    (1,603)  
             
Total $ (48)   $ (1,727)    $ (0.32)   $ (11.50)    $ (71)   $ (1,775)  
             

See Definition and Reconciliation of Non-GAAP Measures.

 

  15 

 

Core Segments

Agribusiness

EBIT for the nine months ended September 30, 2019 included $5 million of program costs related to the GCP, included in SG&A, $1 million of severance and other employee benefit costs related to other industrial initiatives, recorded in COGS, $85 million of PP&E impairment charges at certain facilities subject to the Company’s portfolio rationalization initiatives, recorded in COGS, and an $11 million charge related to the reversal of an expired indemnification asset in connection with an uncertain tax position, recorded in SG&A.

Edible Oil Products

EBIT for the nine months ended September 30, 2019 included $12 million of PP&E impairment charges at certain facilities subject to the Company’s portfolio rationalization initiatives, recorded in COGS, $1 million of severance and other employee benefit costs related to the GCP, recorded in SG&A, and $1 million of acquisition and integration costs related to the acquisition of IOI Loders Croklaan (Loders), included in SG&A.

Milling Products

EBIT for the nine month ended September 30, 2019 included $16 million of impairment charges at certain facilities subject to the Company’s portfolio rationalization initiatives, recorded in COGS, and a $9 million gain related to an arbitration settlement in the U.S.

Corporate and Other

EBIT for the nine months ended September 30, 2020 included $5 million of severance and other employee benefit costs related to the GCP, recorded in SG&A, and $66 million in charges, primarily related to a provision against an aged receivable dating from 2015 that is now deemed uncollectable due to an anticipated legal settlement, of which $51 million was recorded in SG&A, and $15 million was recorded in Other income (expense) - net. Net Income for the nine months ended September 30, 2020 also included a $21 million income tax benefit related to the reversal of a deferred tax asset valuation allowance in Europe.

EBIT for the nine months ended September 30, 2019 included $21 million of severance and other employee benefit costs related to the GCP, included in SG&A, $2 million of acquisition and integration costs related to the acquisition of IOI Loders Croklaan, included in SG&A, and $22 million of impairment charges related to the relocation of the Company’s global headquarters, recorded in SG&A. Net Income also included income tax benefits of $30 million for the nine months ended September 30, 2019, of which $19 million related to the favorable resolution of uncertain tax positions in Asia, and $11 million related to the lapse of statutes of limitations on unrecognized tax benefits in Europe.

Non-core Segments

Sugar & Bioenergy

EBIT for the nine months ended September 30, 2019 included $1,524 million of impairment charges, recorded in COGS, and $79 million of foreign currency losses on intercompany loans no longer classified as permanently invested, recorded in Foreign exchange gains (losses). Both such items related to the classification of the Company’s Brazilian sugar and bioenergy operations as held for sale. EBIT for the nine months ended September 30, 2019 also included restructuring charges of $4 million, recorded in COGS.

 

  16 

 

Ø Consolidated Earnings Data (Unaudited)

 

  Quarter Ended
September 30,
   Nine Months Ended September 30,
(US$ in millions, except per share data) 2020 2019   2020 2019
Net sales $ 10,159    $ 10,323      $ 28,794    $ 30,357   
Cost of goods sold (9,557)   (11,301)     (26,913)   (30,386)  
Gross profit 602    (978)     1,881    (29)  
Selling, general and administrative expenses (352)   (329)     (993)   (969)  
Foreign exchange gains (losses) 54    (129)     75    (147)  
Other income (expense) – net 17    (4)     37    201   
Income (loss) from affiliates 35        (76)   21   
EBIT attributable to noncontrolling interest (a) (1) (5)   (8)     (5)   (12)  
Total Segment EBIT (1) 351    (1,440)     919    (935)  
Interest income       18    22   
Interest expense (56)   (86)     (195)   (249)  
Income tax (expense) benefit (38)   28      (151)   (70)  
Noncontrolling interest share of interest and tax (a) (1) —           
Income (loss) from continuing operations, net of tax 262    (1,488)     594    (1,229)  
Income (loss) from discontinued operations, net of tax —    —      —    —   
Net income (loss) attributable to Bunge (1) 262    (1,488)     594    (1,229)  
Convertible preference share dividends (8)   (8)     (25)   (25)  
Adjustment of redeemable noncontrolling interest 12    —        —   
Net income (loss) available to Bunge common shareholders - basic and diluted $ 266    $ (1,496)     $ 571    $ (1,254)  
Add back convertible preference share dividends (b)   —      25    —   
Net income (loss) available to Bunge common shareholders - diluted $ 274    $ (1,496)     $ 596    $ (1,254)  
           
Net income (loss) per common share diluted attributable to Bunge common shareholders $ 1.84    $ (10.57)     $ 3.98    $ (8.87)  
Weighted–average common shares outstanding - diluted (b) 149    142      150    141   
           

 

(a) The line items “EBIT attributable to noncontrolling interest” and “Noncontrolling interest share of interest and tax” when combined, represent consolidated Net (income) loss attributable to noncontrolling interests on a U.S. GAAP basis of presentation.
(b)  Approximately 8 million common shares that are issuable upon conversion of the convertible preference shares were not dilutive and not included in the weighted-average number of shares outstanding for the three and nine month periods ended September 30, 2019. Accordingly, the related convertible preference share dividends were excluded from Net income (loss) available to Bunge common shareholders - diluted for the three and nine month periods ended September 30, 2019.

 

 

 

 

 

 

  17 

 

Ø Condensed Consolidated Balance Sheets (Unaudited)

 

  September 30, December 31,
(US$ in millions) 2020 2019
Assets    
Cash and cash equivalents $ 291    $ 320   
Trade accounts receivable, net 1,623    1,705   
Inventories (a) 6,463    5,038   
Assets held for sale 395    72   
Other current assets 4,729    3,113   
Total current assets 13,501    10,248   
Property, plant and equipment, net 3,720    4,132   
Operating lease assets 871    796   
Goodwill and other intangible assets, net 1,083    1,194   
Investments in affiliates 583    827   
Other non-current assets 1,003    1,120   
Total assets $ 20,761    $ 18,317   
     
Liabilities and Equity    
Short-term debt $ 1,610    $ 771   
Current portion of long-term debt 509    507   
Trade accounts payable 2,708    2,842   
Current operating lease obligations 233    216   
Liabilities held for sale 283     
Other current liabilities 3,589    2,255   
Total current liabilities 8,932    6,595   
Long-term debt 4,419    3,716   
Non-current operating lease obligations 584    539   
Other non-current liabilities 972    1,040   
Total liabilities 14,907    11,890   
Redeemable noncontrolling interest 403    397   
Total equity 5,451    6,030   
Total liabilities, redeemable noncontrolling interest and equity $ 20,761    $ 18,317   

 

(a) Includes readily marketable inventories of $5,354 million and $3,934 million at September 30, 2020 and December 31, 2019, respectively. Of these amounts, $4,166 million and $2,589 million, respectively, can be attributable to merchandising activities.

 

 

 

 

 

 

 

 

  18 

 

Ø Condensed Consolidated Statements of Cash Flows (Unaudited)

 

  Nine Months Ended September 30,
(US$ in millions) 2020 2019
Operating Activities    
Net income (loss) (1) $ 596    $ (1,220)  
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:    
   Foreign exchange (gain) loss on net debt (126)   152   
   Depreciation, depletion and amortization 323    428   
   Deferred income tax (benefit) 51    (19)  
   Impairment charges   1,664   
   Other, net 177     
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
   Trade accounts receivable (237)   (314)  
   Inventories (1,679)   (55)  
   Secured advances to suppliers (296)   (302)  
   Trade accounts payable and accrued liabilities 260    (298)  
   Advances on sales (119)   (172)  
   Net unrealized (gain) loss on derivative contracts 173    (320)  
   Margin deposits (360)   145   
   Marketable securities 98    (309)  
   Beneficial interest in securitized trade receivables (1,178)   (767)  
   Other, net 181    73   
    Cash provided by (used for) operating activities (2,128)   (1,313)  
Investing Activities    
Payments made for capital expenditures (230)   (378)  
Proceeds from investments 270    373   
Payments for investments (293)   (342)  
Settlement of net investment hedges 67    (45)  
Proceeds from beneficial interest in securitized trade receivables 1,164    800   
Payments for investments in affiliates (14)   (9)  
Other, net 16    25   
    Cash provided by (used for) investing activities 980    424   
Financing Activities    
Net borrowings (repayments) of short-term debt 683    1,069   
Net proceeds (repayments) of long-term debt 796    (27)  
Proceeds from the exercise of options for common shares    
Repurchases of common shares (100)   —   
Dividends paid to common and preference shareholders (237)   (237)  
Other, net (15)   (17)  
    Cash provided by (used for) financing activities 1,129    796   
Effect of exchange rate changes on cash and cash equivalents and restricted cash   (7)  
Net increase (decrease) in cash and cash equivalents and restricted cash (14)   (100)  
Cash and cash equivalents and restricted cash - beginning of period 322    393   
Cash and cash equivalents and restricted cash - end of period $ 308    $ 293   

 

 

 

 

 

  19 

 

Ø Definition and Reconciliation of Non-GAAP Measures

This earnings release contains certain “non-GAAP financial measures” as defined in Regulation G of the Securities Exchange Act of 1934. Bunge has reconciled these non-GAAP financial measures to the most directly comparable U.S. GAAP measures below. These measures may not be comparable to similarly titled measures used by other companies.

Total Segment EBIT and Adjusted Total Segment EBIT

Bunge uses segment earnings before interest and tax (“Segment EBIT”) to evaluate the operating performance of its individual segments. Segment EBIT excludes EBIT attributable to noncontrolling interests. Bunge also uses Core Segment EBIT, Non-Core Segment EBIT and Total Segment EBIT to evaluate the operating performance of Bunge’s Core reportable segments, Non-Core reportable segments, and Total reportable segments together with its corporate and other activities, respectively. Core Segment EBIT is the aggregate of the earnings before interest and taxes of each of Bunge’s Agribusiness, Edible Oil Products, Milling Products, and Fertilizer segments. Non-Core Segment EBIT is the earnings before interest and taxes of Bunge’s Sugar & Bioenergy segment. Total Segment EBIT is the aggregate of the earnings before interest and taxes of Bunge’s Core and Non-Core reportable segments, together with its corporate and other activities.

Adjusted Core Segment EBIT, Adjusted Non-Core Segment EBIT, and Adjusted Total Segment EBIT, are calculated by excluding temporary mark-to-market timing differences as defined in note 3 below, and certain gains and (charges), as described in “Additional Financial Information” above, from Core Segment EBIT, Non-Core Segment EBIT, and Total Segment EBIT, respectively.

Core Segment EBIT, Non-Core Segment EBIT, Total Segment EBIT, Adjusted Core Segment EBIT, Adjusted Non-Core Segment EBIT, and Adjusted Total Segment EBIT are non-GAAP financial measures and are not intended to replace Net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. Bunge’s management believes these non-GAAP measures are a useful measure of its reportable segments’ operating profitability, since the measures allow for an evaluation of segment performance without regard to their financing methods or capital structure. For this reason, operating performance measures such as these non-GAAP measures are widely used by analysts and investors in Bunge’s industries. These non-GAAP measures are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to net income (loss) or any other measure of consolidated operating results under U.S. GAAP.

Net Income (loss) attributable to Bunge to Adjusted Net Income (loss) available for common shareholders

Adjusted Net Income (loss) excludes certain gains and (charges) and temporary mark-to-market timing differences as defined in note 3 below, and is a non-GAAP financial measure. This measure is not a measure of net income (loss) attributable to Bunge, the most directly comparable U.S. GAAP financial measure. It should not be considered as an alternative Net Income (loss) attributable to Bunge, Net Income (loss) or any other measure of consolidated operating results under U.S. GAAP.  Adjusted Net income (loss) is a useful measure of the Company’s profitability.

We also have presented projected adjusted net income per common share for 2020. This information is provided only on a non-GAAP basis without reconciliation to projected net income per common share for 2020, the mostly directly comparable GAAP measure, due to the inability at this time to quantify certain amounts necessary for such reconciliation, including but not limited to future market price movements over the remainder of the year.

  20 

 

Below is a reconciliation of Net income attributable to Bunge, to Total Segment EBIT, and Adjusted Total Segment EBIT:

  Quarter Ended
September 30,
  Nine Months Ended
September 30,
(US$ in millions) 2020 2019    2020 2019
Net income (loss) attributable to Bunge $ 262    $ (1,488)     $ 594    $ (1,229)  
Interest income (5)   (8)     (18)   (22)  
Interest expense 56    86      195    249   
Income tax expense (benefit) 38    (28)     151    70   
Noncontrolling interest share of interest and tax —    (2)     (3)   (3)  
Total Segment EBIT $ 351    $ (1,440)     $ 919    $ (935)  
           
Agribusiness EBIT $ 299    $ 107      $ 1,015    $ 457   
Edible Oil Products EBIT 76    59      173    $ 161   
Milling EBIT 16    14      64    $ 61   
Fertilizer EBIT 29    22      53    $ 30   
Core Segment EBIT $ 420    $ 202      $ 1,305    $ 709   
           
Corporate and Other EBIT $ (92)   $ (99)     $ (274)   $ (77)  
           
Sugar & Bioenergy EBIT 23    (1,543)     (112)   (1,567)  
Non-Core Segment EBIT $ 23    $ (1,543)     $ (112)   $ (1,567)  
           
Total Segment EBIT $ 351    $ (1,440)     $ 919    $ (935)  
Mark-to-market timing difference 161    (25)     186    (47)  
Certain (gains) & charges —    1,744      71    1,775   
Adjusted Total Segment EBIT $ 512    $ 279      $ 1,176    $ 793   
           

 

 

 

 

  21 

 

Below is a reconciliation of Net income attributable to Bunge, to Adjusted Net income (loss):

  Quarter Ended
September 30,
  Nine Months Ended
September 30,
(US$ in millions, except per share data) 2020   2019    2020   2019
Net income (loss) attributable to Bunge $ 262      $ (1,488)     $ 594      $ (1,229)  
Adjustment for Mark-to-market timing difference 126      (20)     146      (38)  
Adjusted for certain (gains) and charges:              
     Severance, employee benefit, and other —              22   
     Impairment charges —      107      —      121   
Sugar restructuring charges —          —       
Expired indemnification asset —      11      —      11   
Gain on arbitration settlement —      —      —      (7)  
Acquisition integration costs —      —      —       
Charges related to assets classified as held for sale —      1,603      —      1,603   
Commercial claim provision —      —      66      —   
Income tax (benefits) charges and Interest (21)     (30)     (21)     (30)  
Adjusted Net income (loss) available for common shareholders $ 367      $ 192      $ 788      $ 460   
Weighted-average common shares outstanding - diluted, adjusted (a) 149      150      150      150   
Adjusted Net income (loss) per common share - diluted $ 2.47      $ 1.28      $ 5.26      $ 3.07   
               
               
Weighted-average common shares outstanding - diluted 149      142      150      141   
Adjustment for stock options, restricted stock units, and convertible preference shares —          —       
Weighted-average common shares outstanding - diluted, adjusted 149      150      150      150   

(a) Approximately 6 million and 8 million outstanding stock options and contingently issuable restricted stock units were not dilutive and not included in the weighted-average number of common shares outstanding for the quarters ended September 30, 2020 and 2019, respectively, and approximately 6 million and 8 million outstanding stock options and contingently issuable restricted stock units were not dilutive and not included in the weighted-average number of common shares outstanding for the nine month periods ended September 30, 2020 and 2019, respectively.

 

 

 

 

 

  22 

 

Ø Notes
(1)A reconciliation of Net income (loss) attributable to Bunge, to Net income (loss) is as follows:
  Nine Months Ended September 30,
  2020    2019
Net income (loss) attributable to Bunge $ 594      $ (1,229)  
EBIT attributable to noncontrolling interest     12   
Noncontrolling interest share of interest and tax (3)     (3)  
Net income (loss) $ 596      $ (1,220)  

 

(2)The Oilseed business included in our Agribusiness segment consists of; global oilseed processing activities, primarily related to the crushing of oilseeds (including soybeans, canola, rapeseed and sunflower seed) into protein meals and vegetable oils; the trading and distribution of oilseeds and oilseed products; and biodiesel production, which is partially conducted through joint ventures.

The Grains business included in our Agribusiness segment primarily consists of; global grain origination activities, which principally conduct the purchasing, cleaning, drying, storing and handling of corn, wheat, barley, rice and oilseeds at our network of grain elevators; logistical services for the distribution of these commodities to our customer markets through our port terminals and transportation assets (including trucks, railcars, barges and ocean vessels); and financial services and activities for customers from whom we purchase commodities and other third parties.

(3)Mark-to-market timing difference comprises the estimated net temporary impact resulting from unrealized period-end gains/losses associated with the fair valuation of certain forward contracts, readily marketable inventories (RMI), and related futures contracts associated with our committed future operating capacity. The impact of these mark-to-market timing differences, which is expected to reverse over time due to the forward contracts, RMI, and related futures contracts being part of an economically hedged position, is not representative of the operating performance of our business.
(4)Dilutive share basis difference - GAAP vs. Adjusted represents the impact of using different weighted-average common shares outstanding in the denominators of the respective EPS calculations. The use of different denominators is necessary as, on a GAAP basis, the Company was in a net loss position, and as such no additional dilutive shares were included in the GAAP EPS calculation, as such inclusion would be antidilutive. However, on an adjusted basis, after excluding certain gains and charges, the Company is in an adjusted net income position, which necessitates the inclusion of additional dilutive shares associated with stock options, restricted stock units, and shares issuable upon the conversion of the convertible preference shares, in the Adjusted EPS calculation.
(5)In the reconciliation of Net income (loss) per common share - diluted (“GAAP EPS”) to Adjusted Net income (loss) per common share - diluted (“Adjusted EPS”), the item “Adjustment of redeemable noncontrolling interest” represents the impact on GAAP EPS of a retained earnings adjustment associated with the carrying amount of the redeemable noncontrolling interest recorded in respect of our 70% ownership interest in Loders. The carrying amount of redeemable noncontrolling interests is the greater of: (i) the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss, equity capital contributions and distributions or (ii) the redemption value. Any resulting increases in the redemption value, in excess of the initial carrying amount, increased or decreased for the noncontrolling interests’ share of net income or loss, equity capital contributions and distributions, are affected by corresponding charges against retained earnings. Additionally, any such charges to retained earnings will affect Net income (loss) available to Bunge common shareholders as part of Bunge’s calculation of GAAP EPS.

Bunge’s management excludes the “Adjustment of redeemable noncontrolling interest” from its calculation of Adjusted EPS, on the basis that it is independent of the Company’s operations. However, such charges reverse only to the extent that Loders’ net income levels result in the carrying amount of redeemable noncontrolling interests, calculated as described above, exceeding the redemption value.

 

 

 

  23 

The following information was filed by Bunge Ltd (BG) on Wednesday, October 28, 2020 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Bunge Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bunge Ltd.

Continue

Assess how Bunge Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bunge Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Expense
Debt
Shares
Earnings
Geography
Product
Income
Cash Flow
Dividend
Other
Inside Bunge Ltd's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover Page
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Changes In Equity And Redeemable Noncontrolling Interests (Unaudited)
Condensed Consolidated Statements Of Changes In Equity And Redeemable Noncontrolling Interests (Unaudited) (Parenthetical)
Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited)
Condensed Consolidated Statements Of Comprehensive Income (Loss) (Unaudited) (Parenthetical)
Condensed Consolidated Statements Of Income (Loss) (Unaudited)
Accounting Pronouncements
Basis Of Presentation, Principles Of Consolidation, And Significant Accounting Policies
Basis Of Presentation, Principles Of Consolidation, And Significant Accounting Policies (Policies)
Basis Of Presentation, Principles Of Consolidation, And Significant Accounting Policies (Tables)
Basis Of Presentation, Principles Of Consolidation, And Significant Accounting Policies - Reconciliation Of Cash, Cash Equivalents, And Restricted Cash (Details)
Commitments And Contingencies
Commitments And Contingencies (Details)
Commitments And Contingencies (Tables)
Debt
Debt (Details)
Debt (Tables)
Derivative Instruments And Hedging Activities
Derivative Instruments And Hedging Activities (Tables)
Derivative Instruments And Hedging Activities - Derivative Positions (Details)
Derivative Instruments And Hedging Activities - Effect Of Derivative Instruments (Details)
Earnings Per Common Share
Earnings Per Common Share (Details)
Earnings Per Common Share (Tables)
Employee Benefit Plans
Employee Benefit Plans (Details)
Equity
Equity (Tables)
Equity - Aoci (Details)
Equity - Share Repurchase Program (Details)
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Assets And Liabilities At Fair Value (Details)
Fair Value Measurements - Reconciliation For Assets And Liabilities Measure At Fair Value Using Level 3 (Details)
Income Taxes
Income Taxes (Details)
Inventories
Inventories (Details)
Inventories (Tables)
Leases
Leases (Tables)
Leases - Components Of Lease Expense (Details)
Leases - Maturities Of Lease Liabilities (Details)
Leases - Narrative (Details)
Leases - Supplemental Cash Flow Information (Details)
Other Current Assets
Other Current Assets (Tables)
Other Current Assets - Marketable Securities And Other Short-Term Investments (Details)
Other Current Assets - Summary Of Other Current Assets (Details)
Other Current Liabilities
Other Current Liabilities (Details)
Other Current Liabilities (Tables)
Other Non-Current Assets
Other Non-Current Assets (Tables)
Other Non-Current Assets - Allowance For Doubtful Accounts (Details)
Other Non-Current Assets - Composition (Details)
Other Non-Current Assets - Receivables From Farmers In Brazil And Allowance Amounts (Details)
Portfolio Rationalization Initiatives
Portfolio Rationalization Initiatives (Tables)
Portfolio Rationalization Initiatives - Composition Of Assets And Liabilities Held For Sale (Details)
Redeemable Noncontrolling Interest
Redeemable Noncontrolling Interest (Details)
Related Party Transactions
Related Party Transactions - Narrative (Details)
Segment Information
Segment Information (Tables)
Segment Information - Financial Information By Segment (Details)
Segment Information - Narrative (Details)
Segment Information - Net Income To Segment Ebit (Details)
Segment Information - Net Sales To External Customers (Details)
Subsequent Event
Subsequent Event (Details)
Trade Accounts Receivable And Trade Receivables Securitization Program
Trade Accounts Receivable And Trade Receivables Securitization Program (Details)
Trade Accounts Receivable And Trade Receivables Securitization Program (Tables)
Trade Accounts Receivable And Trade Receivables Securitization Program - Rollforward Of The Allowance For Credit Losses (Details)
Trade Structured Finance Program
Trade Structured Finance Program (Details)
Ticker: BG
CIK: 1144519
Form Type: 10-Q Quarterly Report
Accession Number: 0001144519-20-000061
Submitted to the SEC: Wed Oct 28 2020 3:51:37 PM EST
Accepted by the SEC: Wed Oct 28 2020
Period: Wednesday, September 30, 2020
Industry: Fats And Oils

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/bg/0001144519-20-000061.htm